Gosh, it is not seeing any support with so good revenue and little debt. Management is pretty quite with no urgency. Anybody has some insight into where it will go
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025